Your browser doesn't support javascript.
loading
POT1 loss-of-function variants predispose to familial melanoma.
Robles-Espinoza, Carla Daniela; Harland, Mark; Ramsay, Andrew J; Aoude, Lauren G; Quesada, Víctor; Ding, Zhihao; Pooley, Karen A; Pritchard, Antonia L; Tiffen, Jessamy C; Petljak, Mia; Palmer, Jane M; Symmons, Judith; Johansson, Peter; Stark, Mitchell S; Gartside, Michael G; Snowden, Helen; Montgomery, Grant W; Martin, Nicholas G; Liu, Jimmy Z; Choi, Jiyeon; Makowski, Matthew; Brown, Kevin M; Dunning, Alison M; Keane, Thomas M; López-Otín, Carlos; Gruis, Nelleke A; Hayward, Nicholas K; Bishop, D Timothy; Newton-Bishop, Julia A; Adams, David J.
Afiliação
  • Robles-Espinoza CD; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK.
  • Harland M; Section of Epidemiology and Biostatistics, Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK.
  • Ramsay AJ; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain.
  • Aoude LG; Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia.
  • Quesada V; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain.
  • Ding Z; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK.
  • Pooley KA; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Pritchard AL; Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia.
  • Tiffen JC; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK.
  • Petljak M; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK.
  • Palmer JM; Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia.
  • Symmons J; Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia.
  • Johansson P; Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia.
  • Stark MS; Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia.
  • Gartside MG; Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia.
  • Snowden H; Section of Epidemiology and Biostatistics, Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK.
  • Montgomery GW; Molecular Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia.
  • Martin NG; Genetic Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia.
  • Liu JZ; Statistical Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK.
  • Choi J; Laboratory of Translational Genomics, National Cancer Institute, Bethesda, MD, USA.
  • Makowski M; Laboratory of Translational Genomics, National Cancer Institute, Bethesda, MD, USA.
  • Brown KM; Laboratory of Translational Genomics, National Cancer Institute, Bethesda, MD, USA.
  • Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Keane TM; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK.
  • López-Otín C; Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain.
  • Gruis NA; Leiden University Medical Centre, Leiden, The Netherlands.
  • Hayward NK; Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia.
  • Bishop DT; Section of Epidemiology and Biostatistics, Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK.
  • Newton-Bishop JA; Section of Epidemiology and Biostatistics, Institute of Cancer and Pathology, University of Leeds, Leeds, LS9 7TF, UK.
  • Adams DJ; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA. UK.
Nat Genet ; 46(5): 478-481, 2014 May.
Article em En | MEDLINE | ID: mdl-24686849
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Modelos Moleculares / Telômero / Predisposição Genética para Doença / Proteínas de Ligação a Telômeros / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa / Oceania Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Modelos Moleculares / Telômero / Predisposição Genética para Doença / Proteínas de Ligação a Telômeros / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa / Oceania Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2014 Tipo de documento: Article